Canine Spectra KC 3 intranasal vaccine is a vaccine shown to be effective against Bordetella bronchiseptica (B.bronch), canine parainfluenza (CPIV), and canine adenovirus type 2 (CAV2) when used in healthy dogs 8 weeks and older.
Shipping : Perishable
CANINE SPECTRA® KC3
Durvet
Canine Adenovirus Type 2-Parainfluenza-Bordetella Bronchiseptica Vaccine
Modified Live Virus
Avirulent Live Culture
INTRANASAL USE
FOR DOGS ONLY
KEEP PRODUCT REFRIGERATED
Indications: This product has been shown to be effective for the vaccination of healthy dogs 8 weeks of age or older against Bordetella bronchiseptica (B.bronch), canine parainfluenza (CPIV), and canine adenovirus type 2 (CAV2). The duration of immunity has not been determined. For more information regarding efficacy and safety data go to productdata.aphis.usda.gov.
Description: Canine Spectra KC3™ vaccine is a combination of immunogenic, attenuated strain of CAV2 and CPIV propagated in cell line tissue cultures with an avirulent live culture of B.bronch.
Directions and dosage: Open the syringe by twisting or tapping the cap against a hard surface to break the heat weld. Aseptically rehydrate the vaccine cake with 1 ml of sterile diluent supplied. Shake until dissolved. Withdraw entire contents into the syringe. Twist and remove needle from syringe and attach enclosed applicator tip. Using the syringe with the applicator tip attached, administer 0.5 mL of rehydrated vaccine into each nostril. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended.
Precautions: FOR INTRANASAL USE IN DOGS ONLY. This vaccine is NOT to be injected. Store in the dark at 35°-46°F (2°-8°C). DO NOT FREEZE. Do not mix with other products, except as specified on the label. A very small percentage of dogs may show sneezing, coughing, or nasal discharge following vaccination. While these are usually temporary signs, consultation with a veterinarian may be indicated if they persist or progressively worsen. In case of anaphylactoid reaction, administer epinephrine. This product has not been tested in pregnant animals. In case of human exposure, contact a physician. Inactivate unused contents before disposal.
|
One Dose with Syringe |
Package contains a one dose vial of vaccine, a one mL vial of diluent & one disposable syringe |
BG102782X |
ISS20XB08 |
| Directions | Open the syringe by twisting or tapping the cap against a hard surface to break the heat weld. Aseptically rehydrate the vaccine cake with 1 mL of sterile diluent supplied. Shake until dissolved. Withdraw entire contents into the syringe. Twist and remove needle from syringe and attach enclosed applicator tip. Using the syringe with the applicator tip attached, administer 0.5 mL of rehydrated vaccine into each nostril. Historically, annual revaccination with this product has been recommended. The need for this booster has not been established. For advice on revaccination frequency and annual booster vaccinations, consultation with a veterinarian is recommended. |
|---|
